- Home
- NBIX vs HLI Comparison
NBIX vs HLI Comparison
Compare NBIX & HLI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NBIX
- HLI
- Stock Information
- Founded
- NBIX 1992
- HLI 1972
- Country
- NBIX United States
- HLI United States
- Employees
- NBIX N/A
- HLI N/A
- Industry
- NBIX Biotechnology: Biological Products (No Diagnostic Substances)
- HLI Investment Managers
- Sector
- NBIX Health Care
- HLI Finance
- Exchange
- NBIX Nasdaq
- HLI Nasdaq
- Market Cap
- NBIX 14.1B
- HLI 14.4B
- IPO Year
- NBIX 1996
- HLI 2015
- Fundamental
- Price
- NBIX $139.41
- HLI $202.54
- Analyst Decision
- NBIX Strong Buy
- HLI Buy
- Analyst Count
- NBIX 18
- HLI 8
- Target Price
- NBIX $161.50
- HLI $205.57
- AVG Volume (30 Days)
- NBIX 713.3K
- HLI 396.0K
- Earning Date
- NBIX 10-29-2025
- HLI 10-29-2025
- Dividend Yield
- NBIX N/A
- HLI 1.18%
- EPS Growth
- NBIX 2.97
- HLI 31.68
- EPS
- NBIX 3.39
- HLI 5.94
- Revenue
- NBIX $2,509,900,000.00
- HLI $2,480,866,000.00
- Revenue This Year
- NBIX $20.66
- HLI $13.85
- Revenue Next Year
- NBIX $14.64
- HLI $14.49
- P/E Ratio
- NBIX $41.44
- HLI $34.25
- Revenue Growth
- NBIX 18.42
- HLI 23.30
- 52 Week Low
- NBIX $84.23
- HLI $137.99
- 52 Week High
- NBIX $154.61
- HLI $208.50
- Technical
- Relative Strength Index (RSI)
- NBIX 53.05
- HLI 56.88
- Support Level
- NBIX $140.56
- HLI $195.30
- Resistance Level
- NBIX $144.04
- HLI $208.50
- Average True Range (ATR)
- NBIX 3.54
- HLI 4.14
- MACD
- NBIX -0.26
- HLI 0.43
- Stochastic Oscillator
- NBIX 35.85
- HLI 66.12
About NBIX Neurocrine Biosciences Inc.
Neurocrine Biosciences Inc engages in the discovery, development, and commercialization of drugs for the treatment of neurological and endocrine-related diseases and disorders in the United States. The company's products include INGREZZA for tardive dyskinesia and chorea associated with Huntington's disease; ALKINDI for adrenal insufficiency; Efmody capsules for classic congenital adrenal hyperplasia; Orilissa tablets for endometriosis; and Oriahnn capsules to treat uterine fibroids.
About HLI Houlihan Lokey Inc.
Houlihan Lokey Inc is an investment bank with expertise in mergers and acquisitions, capital markets, financial restructuring, valuation, and strategic consulting. The firm serves corporations, institutions, and governments world-wide with offices in the United States, Europe, and the Asia-Pacific region. The company operates in three segments. In the Corporate Finance business segment, it provides M&A and capital markets advisory services. Through the Financial Restructuring business segment, the company advises on some of the complex restructurings around the world. The Financial and Valuation Advisory Services business segment provides valuation and financial opinion, and financial and strategic consulting practices in the United States.